JP Morgan Arm

JPMorgan Raises Arm Holdings Price Target to $255

1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$255
from $240 (+6%)
Outcome
Reached
on August 4, 2026
JP Morgan and Arm logos

What the analyst said

JPMorgan analyst Harlan Sur raised the price target on Arm Holdings (NASDAQ: ARM) to $255 (from $240) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ARM trades at $197. The 2 analysts who set a target in the last 3 months range from $320 to $641, with a median of $481. This $255 target is 47% below the median, the lowest on the Street.

Since the note ARM has moved −12% (from $225). 12-month window: day 96 of 365, closes on July 30, 2027.

Track record

This call✓ Target reached on August 4, 2026, 5 days after the note.

Firm track recordJP Morgan: 63% of its 27 targets at least a year old were reached within 12 months (#23 of 26 firms). Accuracy ranking →

Earnings reactionOne of 12 notes after Arm’s Jul 29 results: 2 raised · 7 cut · 2 kept. See every call →

JP Morgan on Arm

JP Morgan price targets on Arm

2 calls from February 5, 2026 to July 30, 2026. The target went from $145 to $255 (+76%). The rating stayed Buy.

JP Morgan targetARM share price
  1. July 30, 2026 This noteTarget raised from $145 (+76%)Buy$255
  2. February 5, 2026Earliest call shownBuy$145
Share

Other analysts on Arm

StoneXHold Kept rating Oct 26 Piper SandlerBuy Initiated coverage Sep 10 $320 Raymond JamesBuy Raised price target +13%, kept rating Aug 25 $641from $565 RosenblattBuy Cut price target −7%, kept rating Jul 31 $250from $270 UBSBuy Cut price target −11%, kept rating Jul 30 $320from $360
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.